Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next-Gen Sequencing

Huiqing Wu's Biography



Huiqing Wu, Assistant Professor, City of Hope National Medical Center and Beckman Research Institute

Huiqing Wu graduated from Shanghai Medical University School of Medicine, Shanghai, China in 1987 (M.D.) and had his M.S. (Master of Science) in Cellular and Molecular Biology from University of Kentucky, Lexington, KY in 1992.  He finished his residency training in Pathology at The Mount Sinai School of Medicine, New York, NY in 2002 and then did his Hematopathology, Surgical Pathology and Research (translational research in prostate cancer) Fellowship at Brigham and Women's Hospital, Harvard Medical School, Boston, MA from 2002 to 2006.  He has been Staff Pathologist and Assistant Professor at City of Hope National Medical Center and Beckman Research Institute, Duarte, CA since 2006.  His research areas include (1) Characterization of small non-coding RNA expression in metastatic renal cell carcinoma and hormonal resistant prostate cancer; (2) MicroRNA signature for clear cell renal cell carcinoma metastasis and prognosis; (3) MicroRNA signature for prostate cancer metastasis and recurrence.  The accomplishments of his laboratory include (A) Being the first to successfully use FFPE tissue cohort samples for whole genome small RNA deep sequencing; (B) Building a 4-miRNA signature to predict clear cell renal cell carcinoma metastasis and prognosis (US patent pending); (C) Revealing a group of small RNAs derived from rRNAs, tRNAs and other non-coding RNAs to be involved in renal cell carcinoma metastasis and progression. 

Huiqing Wu Image

Deep Sequencing, microRNA/Other Novel Small Non-coding RNA, and Renal Cell Carcinoma Metastasis

Thursday, 6 June 2013 at 14:15

Add to Calendar ▼2013-06-06 14:15:002013-06-06 15:15:00Europe/LondonDeep Sequencing, microRNA/Other Novel Small Non-coding RNA, and Renal Cell Carcinoma MetastasisSELECTBIOenquiries@selectbiosciences.com

Whole genome small RNA deep sequencing studies using formalin-fixed paraffin-embedded clinical renal cell carcinoma samples. Discovery and characterization of novel small non-coding small RNAs derived from tRNAs, rRNAs, snoRNAs and other RNAs/RNA fragments by deep sequencing studies of Ago2-coprecipitated small RNAs and clinical renal cell carcinoma tissue cohort.


Add to Calendar ▼2013-06-06 00:00:002013-06-07 00:00:00Europe/LondonNext-Gen SequencingSELECTBIOenquiries@selectbiosciences.com